• ProBioGen, Heidelberg Pharma Ink ATAC Agreement contractpharma
    October 23, 2020
    ProBioGen is conducting cell line development, process development and GMP manufacturing of the mAb intermediates of Heidelberg’s ATAC molecules for cancer.
PharmaSources Customer Service